Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| 1 |
TC Energy
TRP
|
$1.49B |
| 2 |
Constellation Brands
STZ
|
$1.48B |
| 3 |
Broadcom
AVGO
|
$1.35B |
| 4 |
Alcon
ALC
|
$1.28B |
| 5 |
UnitedHealth
UNH
|
$1.03B |
Top Sells
| 1 |
AbbVie
ABBV
|
$2.65B |
| 2 |
Verizon
VZ
|
$1.88B |
| 3 |
Booking.com
BKNG
|
$1.54B |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
$1.35B |
| 5 |
Alphabet (Google) Class C
GOOG
|
$1.35B |
Sector Composition
| 1 | Healthcare | 19.37% |
| 2 | Technology | 16.98% |
| 3 | Consumer Discretionary | 12.52% |
| 4 | Communication Services | 11.95% |
| 5 | Industrials | 8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Johnson & Johnson
JNJ
$427B
| $550M | 0.17% | 3,947,498 -2,181,998 | -36% | -$304M |
|
127
Boeing
BA
$177B
| $546M | 0.17% | 1,499,371 -549,030 | -27% | -$200M |
|
128
SBA Communications
SBAC
$22B
| $540M | 0.17% | 2,400,844 +851,080 | +55% | +$191M |
|
|
ATVI
129
DELISTED
Activision Blizzard Inc.
ATVI
| $518M | 0.16% | 10,981,526 -6,213,480 | -36% | -$293M |
|
130
Waste Management
WM
$91.2B
| $507M | 0.16% | 4,392,955 +427,263 | +11% | +$49.3M |
|
131
Integra LifeSciences
IART
$1.18B
| $506M | 0.16% | 9,055,166 +68,131 | +0.8% | +$3.81M |
|
|
ZEN
132
DELISTED
ZENDESK INC
ZEN
| $504M | 0.16% | 5,664,536 +1,592,848 | +39% | +$142M |
|
133
PayPal
PYPL
$67.1B
| $499M | 0.16% | 4,359,480 +59 | +0% | +$6.75K |
|
134
Charles Schwab
SCHW
$174B
| $499M | 0.16% | 12,413,761 -1,980,392 | -14% | -$79.6M |
|
135
Nutrien
NTR
$28B
| $495M | 0.16% | 9,255,943 +7,815 | +0.1% | +$418K |
|
136
Skyworks Solutions
SWKS
$11.1B
| $492M | 0.16% | 6,370,432 +3,885 | +0.1% | +$300K |
|
137
IQVIA
IQV
$32.4B
| $492M | 0.16% | 3,058,151 +2,188 | +0.1% | +$352K |
|
138
Dayforce
DAY
$11B
| $491M | 0.16% | 9,788,704 +1,119,601 | +13% | +$56.2M |
|
|
RDS.B
139
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $484M | 0.15% | 7,360,817 +232,174 | +3% | +$15.3M |
|
140
Bank of Montreal
BMO
$86.7B
| $478M | 0.15% | 6,323,588 +239,152 | +4% | +$18.1M |
|
141
Alcoa
AA
$8.33B
| $468M | 0.15% | 19,970,844 +1,723,632 | +9% | +$40.4M |
|
|
PARA
142
DELISTED
Paramount Global Class B
PARA
| $457M | 0.15% | 9,166,965 -2,196,141 | -19% | -$110M |
|
143
Essent Group
ESNT
$6.18B
| $450M | 0.14% | 9,571,030 +3,209 | +0% | +$151K |
|
144
Arch Capital
ACGL
$34.2B
| $448M | 0.14% | 12,083,565 -594,073 | -5% | -$22M |
|
145
Cenovus Energy
CVE
$29.9B
| $426M | 0.14% | 48,286,244 +10,717,111 | +29% | +$94.5M |
|
146
Medtronic
MDT
$119B
| $425M | 0.13% | 4,359,542 -2,092,842 | -32% | -$204M |
|
|
PRAH
147
DELISTED
PRA Health Sciences, Inc.
PRAH
| $420M | 0.13% | 4,231,446 +482,211 | +13% | +$47.8M |
|
148
Ultragenyx Pharmaceutical
RARE
$2.89B
| $404M | 0.13% | 6,357,126 +1,694 | +0% | +$108K |
|
149
Marsh & McLennan
MMC
$101B
| $403M | 0.13% | 4,037,610 +1,508,414 | +60% | +$150M |
|
150
Electronic Arts
EA
$43B
| $393M | 0.12% | 3,878,886 -1,117,847 | -22% | -$113M |
|